GLP-1 vs Insulin Aspart

Head-to-head comparison of GLP-1 (Glucagon-like peptide-1 (7-36 amide)) and Insulin Aspart (Insulin aspart (B28-Asp human insulin analog)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyGLP-1Insulin Aspart
CategoryDiabetes & MetabolicDiabetes & Metabolic
Full NameGlucagon-like peptide-1 (7-36 amide)Insulin aspart (B28-Asp human insulin analog)
Molecular Weight3297 Da5825.8 Da
Half-Life1-2 minutesAbout 1-3 hours
Amino Acids3051
Typical DoseResearch-only: 0.1-1.0 pmol/kg/min0.05-0.2 U/kg per meal
RouteIntravenous/SubcutaneousSubcutaneous
Purity≥98%≥98%
Studies Count120011000
Research StatusPre-clinicalApproved

GLP-1 Benefits

  • beta-cell protection
  • improved insulin secretion
  • slower gastric emptying
  • lower postprandial glucose

Insulin Aspart Benefits

  • Fast post-meal glucose lowering
  • Predictable onset
  • Flexible mealtime administration
  • Compatible with pump therapy

GLP-1 Dosing

0.1-1.0 pmol/kg/min IV infusion in research|0.5-10 nM in vitro|continuous delivery in animal studies

Insulin Aspart Dosing

Inject SC immediately before meals|Titrate using glucose monitoring and carbohydrate intake|Can be used in insulin pumps or basal-bolus regimens

GLP-1 Side Effects

  • nausea at pharmacologic exposure
  • tachyphylaxis with continuous exposure
  • headache

Insulin Aspart Side Effects

  • Hypoglycemia
  • Injection-site reactions
  • Weight gain

Research Overview

GLP-1

Native GLP-1 has a very short half-life because of rapid DPP-4 cleavage, so it is mainly used as a mechanistic research peptide. Across animal and cellular studies it reduces beta-cell apoptosis, improves insulin gene expression, and enhances islet resilience.

Insulin Aspart

Research consistently shows faster onset and earlier peak action than regular human insulin. It is commonly studied for meal-time glycemic control and pump-based insulin delivery.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

GLP-1 stacks with:

DPP-4 inhibitorsSGLT2 inhibitorsdiet and exercise

Insulin Aspart stacks with:

Insulin GlargineInsulin Degludec
incretinbeta-cell survivalDPP-4 substraterapid-acting insulinmeal coveragepump-compatible